tm logo
GLYFEX
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 29 Oct 2024

Last Applicant/ Owned by

400 Interpace Parkway

Parsippany

NJ

07054

Serial Number

97640597 filed on 20th Oct 2022

Registration Number

N/A

Correspondent Address

Laurence Rickles

Laurence Rickles TEVA PHARMACEUTICALS USA, INC.

BUILDING A

PARSIPPANY, NJ 07054

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

GLYFEX

Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely, for use in slowing gastric emptying, improving glycemic control, increasing first-phase and second-phase insulin secretion, and in suppression of inappropriate glucagon secretion, and for the treatment and prevention of endocrine conditions and disorders, diabete Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely, for use in slowing gastric emptying, improving glycemic control, increasing first-phase and second-phase insulin secretion, and in suppression of inappropriate glucagon secretion, and for the treatment and prevention of endocrine conditions and disorders, diabetes, diabetic complications, and hormonal diseases and disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97640597

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Oct 2024SOU EXTENSION 2 FILED
29th Oct 2024SOU EXTENSION 2 GRANTED
29th Oct 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29th Oct 2024SOU TEAS EXTENSION RECEIVED
25th Apr 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24th Apr 2024SOU EXTENSION 1 GRANTED
24th Apr 2024SOU EXTENSION 1 FILED
24th Apr 2024SOU TEAS EXTENSION RECEIVED
07th Nov 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12th Sep 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED